← Back to Search

Peer Leader Model for Health Care Utilization (AccessKCTeen2 Trial)

N/A
Waitlist Available
Led By Melissa Millerr, MD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

AccessKCTeen2 Trial Summary

This trial will help to improve sexual and reproductive health/mental health outcomes for teenagers by providing them with educational information and access to free contraception and pregnancy tests.

AccessKCTeen2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Healthcare Utilization from Baseline to 6 months via Participant Survey.

AccessKCTeen2 Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Trial ParticipantsExperimental Treatment1 Intervention
All adolescents will have access to THO+ activities and materials shared by the peer leaders. All adolescents will be asked to complete an eligibility screening survey and baseline survey online or in-person. They will complete short surveys at 2, 4 and 6 months via Twilio text, call, or email. Peer Leaders Investigators will enroll up to 40 Peer Leaders. In addition to the above activities (under intervention trial participant), if a teen is a "peer leader" they will attend a training session in-person or online with our study team to learn about sexual and mental health information and how to share information with their friends (like text or social media). The peer leaders will answer the same surveys described above and will be asked about their Peer Leader experience and how they are sharing the study health information.
Group II: Event Day ParticipantsExperimental Treatment1 Intervention
Adolescents not already in the trial who attend demonstration and clinical care events must enroll as research participants if they want to receive study medications or testing. This again is all optional to teens. This survey will ask for contact information which is required to track study medications and provide testing results, all other survey questions will be optional.
Group III: Adult StakeholdersActive Control1 Intervention
Adults Involved with teens (e.g., parent of teen, member of community, works at community partner organization) that will help promote community based events and provide feedback on events.

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
248 Previous Clinical Trials
935,906 Total Patients Enrolled
Melissa Millerr, MDPrincipal InvestigatorChildren's Mercy Kansas City

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment quota for this medical experiment?

"That is correct. As per information found on clinicaltrials.gov, this medical study has commenced participant recruitment since April 22nd 2022 and will accept up to 250 participants from a single location."

Answered by AI

What are the prerequisites for participation in this clinical experiment?

"This research project is seeking 250 individuals aged 14 - 100 who have access to healthcare and meet the following criteria: INTERVENTION TRIAL PARTICIPANTS & Peer Leaders (ADOLESCENTS) Inclusion Criteria, Aged between 14-18 years old."

Answered by AI

Is there presently an ongoing call for participants in this clinical experiment?

"Affirmative. According to the information on clinicaltrials.gov, recruitment for this medical trial is currently in progress; it was initially advertised April 22nd 2022 and updated as recently as July 1st 2022. The project requires 250 participants from a single centre."

Answered by AI

Is the cohort of this study inclusive to geriatric individuals?

"Per the study's prerequisites, individuals between 14 and 100 years of age are able to join the trial."

Answered by AI
~18 spots leftby May 2025